Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOPROL-XL in Hypertensive Pediatric Subjects
NCT00255528Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of s-metoprolol in hypertension (HTN) (4 arms), sponsored by AstraZeneca. Primary endpoint: Change in sitting Systolic Blood Pressure from baseline to end of treatment at 4 weeks. Started Jul 2002; status: completed.
02
Drugs
s-metoprolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00255528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00255528.